Antiplatelet and antithrombotic therapy in PCI: a balancing act

Learning Objectives

  • To learn about the balance between ischaemic versus bleeding risk in contemporary PCI scenarios
  • To identify how to manage patients needing both antiplatelet and anticoagulant agents
  • To analyse how new antithrombotic agents may be applied into practice

Presentations available when logged in:

  • Debate: oral anticoagulant should be continued throughout PCI
  • Presentation of a case included in the ARCTIC trial
  • Take-home message
  • Balancing ischaemic versus bleeding risk in an individual patient
  • Presentation of a case included in the WOEST trial
  • Introduction and objectives
  • Debate - Oral anticoagulant should be stopped before elective PCI